Pharmacotherapy Publishing Inc
View my basket
Atypon Link logo

You have no access to this article

Community-Associated Methicillin-Resistant Staphylococcus aureus: A Review


Author(s): Michael J. Rybak | Kerry L. LaPlante, Pharm.D.
doi: 10.1592/phco.25.1.74.55620
Prev | Table of contents | Next
 
View PDF article (655 K) View references
Email this link
 What is RSS?
Trouble viewing articles as PDF?
 
  Pharmacotherapy
 
Print ISSN: 0277-0008
Volume: 25 | Issue: 1
Cover date: January 2005
Page(s): 74-85
 
 
  Keywords
 
community-associated methicillin-resistant Staphylococcus aureus, community-associated MRSA, CA-MRSA, SCCmec IV, staphylococcal cassette chromosome, Panton-Valentine leucocidin, MRSA, disk diffusion test, clindamycin, daptomycin, trimethoprim-sulfamethoxazole
 
  Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a common bacterial pathogen responsible for a variety of infections in both children and adults. Treatment of infections caused by this organism is problematic due to its resistance to many drugs. Recent reports of community-associated MRSA (CA-MRSA) infections in patients with no known risk factors have serious public health implications. Therapeutic options for these infections are untested; therefore, the potential exists for high morbidity and mortality. Recently, clinical definitions have been established, and new molecular approaches have allowed investigators to distinguish CA-MRSA more easily from traditional nosocomial-derived MRSA strains. Identifying potential risk factors for CA-MRSA acquisition and fully characterizing the epidemiologic, clinical, and molecular properties of these strains are necessary to provide effective therapeutic guidelines.

 
  Author(s) affiliations
 
1. Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, and the School of Medicine, Wayne State University, the Detroit Receiving Hospital and University Health Center, Detroit, Michigan.
Address reprint requests to Michael J. Rybak, Pharm.D., Anti-Infective Research Laboratory, Pharmacy Practice – 4148, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, 259 Mack Avenue, Detroit, MI 48201; e-mail: m.rybak@wayne.edu.
2. Department of Pharmacy Practice, University of Rhode Island, Kingston, Rhode Island.
 
  This article has been cited by:
1.
 
Agents for the Decolonization of Methicillin-Resistant Staphylococcus aureus.
Kevin W. McConeghy, , Dennis J. Mikolich, , Kerry L. LaPlante, .
Pharmacotherapy |  29 |  3 |  263-280
View Header/Abstract | View PDF article (316 KB) | PDF Plus (322 KB) 
2.
 
Usefulness of Multiple-Locus VNTR Fingerprinting in detection of clonality of community- and hospital-acquired Staphylococcus aureus isolates.
Agnieszka Luczak-Kadlubowska, Artur Sabat, Arjana Tambic-Andrasevic, Marina Payerl-Pal, Jolanta Krzyszton-Russjan, Waleria Hryniewicz.
Antonie van Leeuwenhoek |  94 |  4 |  543-553
CrossRef
3.
 
Epidural Abscess Due to Spinal Cord Stimulator Trial.
Jacob J. Rauchwerger, Gregg H. Zoarski, Romanth Waghmarae, Ronald P. Rabinowitz, Joel L. Kent, Enslin F. Aldrich, Carey Walter F. Closson.
Pain Practice |  8 |  4 |  324-328
CrossRef
4.
 
A Review of Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections.
Rachel J. Gorwitz.
The Pediatric Infectious Disease Journal |  27 |  1 |  1-7
CrossRef
5.
 
Methicillin-resistant Staphylococcus aureus: From the hospital to the community.
Armando Paez, Daniel Skiest.
Current Infectious Disease Reports |  10 |  1 |  14
CrossRef
6.
 
Burden of Methicillin-Resistant Staphylococcus aureus: Focus on Clinical and Economic Outcomes.
Thomas P. Lodise, Jr., Peggy S. McKinnon.
Pharmacotherapy |  27 |  7 |  1001-1012
View Header/Abstract | View PDF article (106 KB) | PDF Plus (141 KB) 
7.
 
Community-Acquired Methicillin-Resistant Staphylococcus Aureus Skin Infections.
Philip R Cohen.
American Journal of Clinical Dermatology |  8 |  5 |  259-270
CrossRef
8.
 
Antimicrobial Susceptibility and Staphylococcal Chromosomal Cassette mec Type in Community- and Hospital-Associated Methicillin-Resistant Staphylococcus aureus.
Kerry L. LaPlante, Michael J. Rybak, Muhammad Amjad, Glenn W. Kaatz.
Pharmacotherapy |  27 |  1 |  3-10
View Header/Abstract | View References | View PDF article (96 KB) 
9.
 
Skin, Soft Tissue, Bone, and Joint Infections in Hospitalized Patients: Epidemiology and Microbiological, Clinical, and Economic Outcomes • .
Benjamin A. Lipsky, John A. Weigelt, Vikas Gupta, Aaron Killian, Michael M. Peng.
Infection Control and Hospital Epidemiology |  28 |  11 |  1290
CrossRef
10.
 
Antimicrobial Resistance in the Hospital Setting: Impact, Trends, and Infection Control Measures.
Gary E. Stein, .
Pharmacotherapy |  25 |  10part2 |  44S-54S
View Header/Abstract | View References | View PDF article (98 KB) 
11.
 
MRSA – what is it, and how do we deal with the problem?.
John F Barrett.
Expert Opinion on Therapeutic Targets |  9 |  2 |  253-265
CrossRef